Skip to content

Comparison the number of red cell transfusion units between preoperative plasma transfusion and no plasma transfusion strategy in cirrhotic patients with upper gastrointestinal bleeding and prolonged INR level: An open-label, randomized multicenter trial.

Comparison the number of red cell transfusion units between preoperative plasma transfusion and no plasma transfusion strategy in cirrhotic patients with upper gastrointestinal bleeding and prolonged INR level: An open-label, randomized multicenter trial.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20251121001
Enrollment
80
Registered
2025-11-21
Start date
2025-06-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with cirrhosis and coagulopathy, indicated by a prolonged INR, who present with gastrointestinal bleeding. Cirrhosis, Coagulopathy, Gastrointestinal bleeding, Transfusion, Fresh frozen plasma

Interventions

In the no plasma transfusion strategy group, no fresh frozen plasma (FFP) will be given before endoscopy,Two units of FFP with 10 mg of chlorpheniramine as premedication will be given before endoscopy
Experimental Procedure/Surgery,No Intervention Procedure/Surgery
No plasma transfusion,Control

Sponsors

Chulalongkorn University
Lead Sponsor
Maharat Nakhon Ratchasima Hospital
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Cirrhosis patients diagnosed by clinical signs and/or liver function tests and/or imaging and/or liver biopsy, 2) Age 18 to 80 years, 3) The international normalized ratio (INR) between 1.5 and 2.5, and the INR level should be obtained no more than 1 month before recruitment. , 4) Patients presenting with upper gastrointestinal bleeding at either the emergency department or the outpatient clinic., 5) Intention for therapeutic endoscopy to address the bleeding lesion.

Exclusion criteria

Exclusion criteria: 1) Hereditary or acquired coagulopathy other than liver diseases, 2) Evidence of hemodynamic instability that requires inotropic support to sustain the mean arterial pressure (MAP) of 65 mmHg or more), 3) Uncontrolled infection with septic shock, 4) Renal insufficiency (CrCl less than 10 ml/min), 5) Taking antiplatelet and/or anticoagulant, 6) Receiving fresh frozen plasma before enrollment

Design outcomes

Primary

MeasureTime frame
Unit of red cell transfusion 14 days after admission Number of red cell unit

Secondary

MeasureTime frame
Unit of red cell transfusion within 6 hours 6 hour after endoscopy Extracted from electronic medical records,Unit of red cell transfusion 6-24 hours 6-24 hour after endoscopy Extracted from electronic medical records,Unit of red cell transfusion after 24 hours 24 hours after endoscopy until discharge or up to 14 days after hospitalization Extracted from electronic medical records,Hemoglobin 12-24 hours after endoscopy Extracted from electronic medical records,INR level 12-24 hours after endoscopy Extracted from electronic medical records,Time to endoscopy During hospitalization Extracted from electronic medical records,Number of platelet transfusion During hospitalization Extracted from electronic medical records,Number of plasma transfusion During hospitalization Extracted from electronic medical records,Volume of platelet transfusion During hospitalization Extracted from electronic medical records,Volume of plasma transfusion During hospitalization Extracted from electronic medical records,Transfusion related adverse event During hospitalization Extracted from electronic medical records,Bleeding complication 14 days after endoscopy Extracted from electronic medical records and patient report outcome,Length of hospital stay During hospitalization Extracted from electronic medical records,Length of ICU stay During hospitalization Extracted from electronic medical records,Mortality 1 and 3 months after endoscopy Extracted from electronic medical records and patient/relative report outcome

Countries

Thailand

Contacts

Public ContactNuanrat Cheerasiri

Chulalongkorn University

Nuanrat.t@gmail.com044235870

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026